“POSSIBILITIES OF USING RUXOLITINIB TO IMPROVE THE RESULTS OF Allo-HSCT (LITERATURE REVIEW)”. 2019. Voprosy Onkologii 65 (3): 330-36. https://doi.org/10.37469/0507-3758-2019-65-3-330-336.